Johan Michiels
Overview
Explore the profile of Johan Michiels including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
789
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Situma S, Omondi E, Nyakarahuka L, Odinoh R, Mweu M, Mureithi M, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772234
Although the highlands of East Africa lack the geo-ecological landmarks of Rift Valley fever (RVF) disease hotspots to participate in cyclic RVF epidemics, they have recently reported growing numbers of...
2.
Gemander N, Kemlin D, Depickere S, Kelkar N, Sharma S, Pannus P, et al.
Vaccine
. 2024 Nov;
44:126544.
PMID: 39608249
Background: Clinical risk factors of deficient immune responses to COVID-19 mRNA vaccination in SARS-CoV-2 naive hemodialysis recipients (HDR) have already been identified. Clinical factors influencing hybrid immunity induced by SARS-CoV-2...
3.
Gemander N, Kemlin D, Depickere S, Kelkar N, Pannus P, Sharma S, et al.
Kidney Int Rep
. 2024 Mar;
9(3):635-648.
PMID: 38481503
Introduction: Comorbidities and immunosuppressive therapies are associated with reduced immune responses to primary COVID-19 mRNA vaccination in kidney transplant recipients (KTRs). In healthy individuals, prior SARS-COV-2 infection is associated with...
4.
Mertes H, Rezende A, Brosius I, Naesens R, Michiels J, deBlock T, et al.
Ann Intern Med
. 2023 Jul;
176(8):1141-1143.
PMID: 37487213
No abstract available.
5.
Brosius I, Van Dijck C, Coppens J, Vandenhove L, Bangwen E, Vanroye F, et al.
J Med Virol
. 2023 May;
95(5):e28769.
PMID: 37212312
The risk of infection after exposure to clade IIb mpox virus (MPXV) is unknown, and potential presymptomatic shedding of MPXV remains to be demonstrated. High-risk contacts of mpox patients were...
6.
Sahun M, Privat-Maldonado A, Lin A, De Roeck N, Van der Heyden L, Hillen M, et al.
ACS Sustain Chem Eng
. 2023 Apr;
11(13):5206-5215.
PMID: 37034498
As recently highlighted by the SARS-CoV-2 pandemic, viruses have become an increasing burden for health, global economy, and environment. The control of transmission by contact with contaminated materials represents a...
7.
Pannus P, Depickere S, Kemlin D, Georges D, Houben S, Olislagers V, et al.
Vaccine
. 2023 Mar;
41(17):2829-2836.
PMID: 36997386
Background: Nursing home residents, a frail and old population group, respond poorly to primary mRNA COVID-19 vaccination. A third dose has been shown to boost protection against severe disease and...
8.
Pannus P, Depickere S, Kemlin D, Houben S, Neven K, Heyndrickx L, et al.
PLOS Glob Public Health
. 2023 Mar;
2(12):e0001308.
PMID: 36962838
Fractional dosing of COVID-19 vaccines could accelerate vaccination rates in low-income countries. Dose-finding studies of the mRNA vaccine BNT162b2 (Pfizer-BioNTech) suggest that a fractional dose induces comparable antibody responses to...
9.
Rezende T, Macera G, Heyndrickx L, Michiels J, Coppens S, Thibaut H, et al.
Microbiol Spectr
. 2023 Feb;
:e0502722.
PMID: 36786659
Here, we report the validation of a new reporter cell line, Hec1a-IFNB-Luc, for use in inhibition studies of various flaviviruses relevant to human pathology. The reporter system allows the detection...
10.
Kemlin D, Gemander N, Depickere S, Olislagers V, Georges D, Waegemans A, et al.
Am J Transplant
. 2023 Feb;
23(5):649-658.
PMID: 36773936
As solid organ transplant recipients are at high risk of severe COVID-19 and respond poorly to primary SARS-CoV-2 mRNA vaccination, they have been prioritized for booster vaccination. However, an immunological...